Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/43312
Title: Advances and challenges in modeling inherited peripheral neuropathies using iPSCs
Authors: Van Lent, Jonas
Prior, Robert
Siles, Gonzalo Perez
Cutrupi, Anthony N.
Kennerson, Marina L.
VANGANSEWINKEL, Tim 
WOLFS, Esther 
Mukherjee-Clavin, Bipasha
Nevin, Zachary
Judge, Luke
Conklin, Bruce
Tyynismaa, Henna
Clark , Alex J.
Bennett, David L.
Van Den Bosch , Ludo
Saporta, Mario
Timmerman, Vincent
Issue Date: 2024
Publisher: SPRINGERNATURE
Source: EXPERIMENTAL AND MOLECULAR MEDICINE,
Abstract: Inherited peripheral neuropathies (IPNs) are a group of diseases associated with mutations in various genes with fundamental roles in the development and function of peripheral nerves. Over the past 10 years, significant advances in identifying molecular disease mechanisms underlying axonal and myelin degeneration, acquired from cellular biology studies and transgenic fly and rodent models, have facilitated the development of promising treatment strategies. However, no clinical treatment has emerged to date. This lack of treatment highlights the urgent need for more biologically and clinically relevant models recapitulating IPNs. For both neurodevelopmental and neurodegenerative diseases, patient-specific induced pluripotent stem cells (iPSCs) are a particularly powerful platform for disease modeling and preclinical studies. In this review, we provide an update on different in vitro human cellular IPN models, including traditional two-dimensional monoculture iPSC derivatives, and recent advances in more complex human iPSC-based systems using microfluidic chips, organoids, and assembloids. Inherited peripheral neuropathies are diseases that cause damage to the motor and sensory nervous system. Despite progress in understanding these diseases, effective treatments are still hard to find. This study looks at using induced pluripotent stem cells (iPSCs - cells that can turn into any type of cell in the body) to mimic the disease and find possible drug targets. The scientists used iPSCs to create different nerve cells and Schwann cells (cells that support nerve function). They studied these cells to see how the disease affects them. The study found that models made from iPSCs can accurately copy key aspects of the disease, providing valuable insights that add to findings from animal models. This research could lead to new treatments for inherited peripheral neuropathies.This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.
Notes: Timmerman, V (corresponding author), Univ Antwerp, Dept Biomed Sci, Peripheral Neuropathy Res Grp, B-2610 Antwerp, Belgium.; Timmerman, V (corresponding author), Inst Born Bunge, Lab Neuromuscular Pathol, B-2610 Antwerp, Belgium.
vincent.timmerman@uantwerpen.be
Document URI: http://hdl.handle.net/1942/43312
ISSN: 1226-3613
e-ISSN: 2092-6413
DOI: 10.1038/s12276-024-01250-x
ISI #: 001237102900006
Rights: The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creativecommons.org/licenses/by/4.0/.
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
Advances and challenges in modeling inherited peripheral neuropathies using iPSCs.pdfPublished version1.78 MBAdobe PDFView/Open
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.